A combined approach using transporter-flux assays and mass spectrometry to examine psychostimulant street drugs of unknown content

ACS Chemical Neuroscience

Volumn 4, Issue 1, 2013, Pages 182-190

  Rosenauer, Rudolf ^a   Luf, Anton ^a   Holy, Marion ^a   Freissmuth, Michael ^a   Schmid, Rainer ^a   Sitte, Harald H ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

2C B; Amphetamine; bath salts; combo; mass spectrometry; MDPV; psychostimulants

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; 4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID CARRIER; 4 AMINOBUTYRIC ACID TRANSPORTER 1; 4 FLUORAMPHETAMINE; 4' METHYLMETHCATHINONE; AMPHETAMINE; CAFFEINE; DEXAMPHETAMINE; DOPAMINE; METHAMPHETAMINE; METHYLONE; METOCLOPRAMIDE; NORADRENALIN; PARACETAMOL; SEROTONIN; STREET DRUG; UNCLASSIFIED DRUG;

AMINO ACID TRANSPORT; ANIMAL TISSUE; ARTICLE; ASSAY; CONTROLLED STUDY; ELECTROSPRAY MASS SPECTROMETRY; HUMAN; HUMAN CELL; IC 50; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

CENTRAL NERVOUS SYSTEM STIMULANTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DESIGNER DRUGS; GABA PLASMA MEMBRANE TRANSPORT PROTEINS; HEK293 CELLS; HUMANS; MASS SPECTROMETRY; PSYCHOTROPIC DRUGS; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; STREET DRUGS; SUBSTANCE ABUSE DETECTION; VESICULAR MONOAMINE TRANSPORT PROTEINS;

MUSCOVY DUCK PARVOVIRUS;

EID: 84872525056     PISSN: None     EISSN: 19487193     Source Type: Journal    
DOI: 10.1021/cn3001763     Document Type: Article

References (31)

1. Carroll, F. I., Lewin, A. H., Mascarella, S. W., Seltzman, H. H., and Reddy, P. A. (2012) Designer drugs: a medicinal chemistry perspective Ann. N.Y. Acad. Sci. 1248, 18-38
2. Steinkellner, T., Yang, J.-W., Montgomery, T. R., Chen, W.-Q., Winkler, M.-T., Sucic, S., Lubec, G., Freissmuth, M., Elgersma, Y., Sitte, H. H., and Kudlacek, O. (2012) Ca2+/Calmodulin-dependent Protein Kinase IIα (αCaMKII) Controls the Activity of the Dopamine Transporter: Implications for Angelman Syndrome J. Biol. Chem. 287, 29627-29635
3. Kristensen, A. S., Andersen, J., Jørgensen, T. N., Sørensen, L., Eriksen, J., Loland, C. J., Strømgaard, K., and Gether, U. (2011) SLC6 neurotransmitter transporters: structure, function, and regulation Pharmacol. Rev. 63, 585-640
4. Sitte, H. H. and Freissmuth, M. (2010) The reverse operation of Na(+)/Cl(-)-coupled neurotransmitter transporters - why amphetamines take two to tango J. Neurochem. 112, 340-355
5. Rothman, R. B. and Baumann, M. H. (2002) Serotonin releasing agents. Neurochemical, therapeutic and adverse effects Pharmacol., Biochem. Behav. 71, 825-836 (Pubitemid 34219232)
6. Schicker, K., Uzelac, Z., Gesmonde, J., Bulling, S., Stockner, T., Freissmuth, M., Boehm, S., Rudnick, G., Sitte, H. H., and Sandtner, W. (2012) Unifying concept of serotonin transporter-associated currents J. Biol. Chem. 287, 438-445
7. Hilber, B., Scholze, P., Dorostkar, M. M., Sandtner, W., Holy, M., Boehm, S., Singer, E. A., and Sitte, H. H. (2005) Serotonin-transporter mediated efflux: A pharmacological analysis of amphetamines and non-amphetamines Neuropharmacology 49, 811-819 (Pubitemid 41483887)
8. Scholze, P., Zwach, J., Kattinger, A., Pifl, C., Singer, E. A., and Sitte, H. H. (2000) Transporter-mediated release: a superfusion study on human embryonic kidney cells stably expressing the human serotonin transporter J. Pharmacol. Exp. Ther. 293, 870-878 (Pubitemid 30417853)
9. Beuming, T., Kniazeff, J., Bergmann, M. L., Shi, L., Gracia, L., Raniszewska, K., Newman, A. H., Javitch, J. A., Weinstein, H., Gether, U., and Loland, C. J. (2008) The binding sites for cocaine and dopamine in the dopamine transporter overlap Nat. Neurosci. 11, 780-789
10. Administration, D. E. (2011) Schedules of Controlled Substances: Temporary Placement of Three Synthetic Cathinones Into Schedule I Fed. Regist. 76, 65471-65475
11. Baumann, M. H., Ayestas, M. A., Partilla, J. S., Sink, J. R., Shulgin, A. T., Daley, P. F., Brandt, S. D., Rothman, R. B., Ruoho, A. E., and Cozzi, N. V. (2012) The designer methcathinone analogs, mephedrone and methylone, are substrates for monoamine transporters in brain tissue Neuropsychopharmacology 37, 1192-203
12. Baumann, M. H., Partilla, J. S., Lehner, K. R., Thorndike, E. B., Hoffman, A. F., Holy, M., Rothman, R. B., Goldberg, S. R., Lupica, C. R., Sitte, H. H., Brandt, S. D., Tella, S. R., Cozzi, N. V, and Schindler, C. W. (2012) Powerful Cocaine-Like Actions of 3,4-Methylenedioxypyrovalerone (MDPV), a Principal Constituent of Psychoactive "Bath Salts" Products Neuropsychopharmacology 10.1038/npp.2012.204
13. Simmler, L. D., Buser, T. A., Donzelli, M., Schramm, Y., Dieu, L.-H., Huwyler, J., Chaboz, S., Hoener, M. C., and Liechti, M. E. (2012) Pharmacological characterization of designer cathinones in vitro Br. J. Pharmacol. 10.1111/j.1476-5381.2012.02145.x
14. Schifano, F., Albanese, A., Fergus, S., Stair, J. L., Deluca, P., Corazza, O., Davey, Z., Corkery, J., Siemann, H., Scherbaum, N., Farre', M., Torrens, M., Demetrovics, Z., and Ghodse, A. H. (2011) Mephedrone (4-methylmethcathinone; "meow meow"): chemical, pharmacological and clinical issues Psychopharmacology (Berlin, Ger.) 214, 593-602
15. EMCDDA. (2011) 2011 Annual report on the state of the drugs problem in Europe. http://www.emcdda.europa.eu/publications/annual-report/2011.
16. Villalobos, C. A., Bull, P., Sáez, P., Cassels, B. K., and Huidobro-Toro, J. P. (2004) 4-Bromo-2,5-dimethoxyphenethylamine (2C-B) and structurally related phenylethylamines are potent 5-HT2A receptor antagonists in Xenopus laevis oocytes Br. J. Pharmacol. 141, 1167-74 (Pubitemid 38582254)
17. Sitte, H. H., Singer, E. A., and Scholze, P. (2002) Bi-directional transport of GABA in human embryonic kidney (HEK-293) cells stably expressing the rat GABA transporter GAT-1 Br. J. Pharmacol. 1, 93-102 (Pubitemid 34102102)
18. Seidel, S., Singer, E. A., Just, H., Farhan, H., Scholze, P., Kudlacek, O., Holy, M., Koppatz, K., Krivanek, P., Freissmuth, M., and Sitte, H. H. (2005) Amphetamines Take Two to Tango: an Oligomer-Based Counter-Transport Model of Neurotransmitter Transport Explores the Amphetamine Action Mol. Pharmacol. 67, 140-151 (Pubitemid 40069974)
19. Rothman, R. B., Baumann, M. H., Dersch, C. M., Romero, D. V, Rice, K. C., Carroll, F. I., and Partilla, J. S. (2001) Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin Synapse 39, 32-41
20. Scholze, P., Zwach, J., Kattinger, A., Pifl, C., Singer, E. A., and Sitte, H. H. (2000) Transporter-Mediated Release: A Superfusion Study on Human Embryonic Kidney Cells Stably Expressing the Human Serotonin Transporter 1 J. Pharmacol. Exp. Ther. 293, 870-878 (Pubitemid 30417853)
21. Scholze, P., Sitte, H. H., and Singer, E. A. (2001) Substantial loss of substrate by diffusion during uptake in HEK-293 cells expressing neurotransmitter transporters Neurosci. Lett. 309, 173-176 (Pubitemid 32763167)
22. Wall, S. C., Gu, H., and Rudnick, G. (1995) Biogenic amine flux mediated by cloned transporters stably expressed in cultured cell lines: amphetamine specificity for inhibition and efflux Mol. Pharmacol. 47, 544-550
23. Sitte, H. H., Scholze, P., Schloss, P., Pifl, C., and Singer, E. A. (2000) Characterization of carrier-mediated efflux in human embryonic kidney 293 cells stably expressing the rat serotonin transporter: a superfusion study J. Neurochem. 74, 1317-1324 (Pubitemid 30104331)
24. Baumann, M. H., Rutter, J. J., and Auerbach, S. B. (1993) Intravenous administration of the serotonin agonist m-chlorophenylpiperazine (mCPP) increases extracellular serotonin in the diencephalon of awake rats Neuropharmacology 32, 1381-1386 (Pubitemid 24023022)
25. Baumann, M. H., Ayestas, M. A., Dersch, C. M., and Rothman, R. B. (2001) 1-(m-chlorophenyl)piperazine (mCPP) dissociates in vivo serotonin release from long-term serotonin depletion in rat brain Neuropsychopharmacology 24, 492-501 (Pubitemid 32244310)
26. Pettibone, D. J. and Williams, M. (1984) Serotonin-releasing effects of substituted piperazines in vitro Biochem. Pharmacol. 33, 1531-1535 (Pubitemid 14105029)
27. Eriksson, E., Engberg, G., Bing, O., and Nissbrandt, H. (1999) Effects of mCPP on the extracellular concentrations of serotonin and dopamine in rat brain Neuropsychopharmacology 20, 287-296 (Pubitemid 29067408)
28. Pavlic, M., Schubert, B., Libiseller, K., and Oberacher, H. (2010) Comprehensive identification of active compounds in tablets by flow-injection data-dependent tandem mass spectrometry combined with library search Forensic Sci. Int. 197, 40-47
29. Sammler, E. M., Foley, P. L., Lauder, G. D., Wilson, S. J., Goudie, A. R., and O'Riordan, J. I. (2010) A harmless high? Lancet 376, 742
30. Bulling, S., Schicker, K., Zhang, Y.-W., Steinkellner, T., Stockner, T., Gruber, C. W., Boehm, S., Freissmuth, M., Rudnick, G., Sitte, H. H., and Sandtner, W. (2012) The mechanistic basis for noncompetitive ibogaine inhibition of serotonin and dopamine transporters J. Biol. Chem. 287, 18524-18534
31. Sucic, S., Dallinger, S., Zdrazil, B., Jørgensen, T. N., Holy, M., Kudlacek, O., Seidel, S., Cha, J. H., Gether, U., Newman, A. H., Ecker, G. F., Freissmuth, M., and Sitte, H. H. (2010) The N Terminus of Monoamine Transporters Is a Lever Required for the Action of Amphetamines J. Biol. Chem. 285, 10924-10938